Skip to main content
. 2016 Sep 29;2016:6273298. doi: 10.1155/2016/6273298

Table 2.

Embryo development times and parameters levels.

PCOS patients treated with folic acid (group I) PCOS patients treated with myoinositol plus folic acid (group II) Patients without PCOS (group III)
E2 Progesterone on the day of ovulation induction SOD Catalase E2 Progesterone on the day of ovulation induction SOD Catalase E2 Progesterone on the day of ovulation induction SOD Catalase
t 1 r −0.164 0.038 −0.484 0.082 −0.358 0.128 −0.036 0.293 −0.055 −0.055 −0.001 0.376
p 0.210 0.775 <0.001 0.533 0.009 0.366 0.801 0.035 0.579 0.581 0.993 <0.001

t 2 r −0.130 0.284 0.402 0.036 −0.146 0.273 −0.092 0.190 −0.057 0.085 −0.093 0.400
p 0.323 0.028 0.001 0.787 0.303 0.050 0.515 0.178 0.561 0.390 0.343 <0.001

t 5 r −0.316 −0.122 −0.408 0.338 −0.365 −0.309 0.154 0.627 −0.084 0.137 −0.016 0.159
p 0.014 0.352 0.001 0.008 0.008 0.026 0.276 <0.001 0.392 0.163 0.868 0.106

t M r 0.028 −0.041 −0.053 −0.014 0.234 0.159 0.120 0.043 −0.136 0.086 −0.335 −0.137
p 0.831 0.758 0.689 0.915 0.096 0.260 0.396 0.765 0.168 0.382 <0.001 0.162

This table shows only the significant correlations between embryo development times and the level of oestradiol and progesterone in serum and SOD and CAT in follicular fluid.